Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults.
Kendra D SimsPengxiao Carol WeiJoanne M PenkoSusan HennessyPamela G CoxsonNita H MukandBrandon K BellowsDhruv S KaziYiyi ZhangRoss BoylanAndrew E MoranKirsten BibbinsPublished in: Hypertension (Dallas, Tex. : 1979) (2024)
Among low-risk adults with stage 1 hypertension, substantial benefits to cardiovascular health could be achieved through public policy that promotes the adoption of nonpharmacologic therapy.